(Q44953741)

English

Effects of pioglitazone and glimepiride on glycemic control and insulin sensitivity in Mexican patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, parallel-group trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 December 2017

Effects of pioglitazone and glimepiride on glycemic control and insulin sensitivity in Mexican patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, parallel-group trial (English)

1 reference

Europe PubMed Central

7 December 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

multicenter clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Meng Tan

1

1 reference

Europe PubMed Central

7 December 2017

Don Johns

2

1 reference

Europe PubMed Central

7 December 2017

Guillermo González Gálvez

3

1 reference

Europe PubMed Central

7 December 2017

Oscar Antúnez

4

1 reference

Europe PubMed Central

7 December 2017

Guadalupe Fabián

5

1 reference

Europe PubMed Central

7 December 2017

Fernando Flores-Lozano

6

1 reference

Europe PubMed Central

7 December 2017

Sergio Zúñiga Guajardo

7

1 reference

Europe PubMed Central

7 December 2017

Eduardo Garza

8

1 reference

Europe PubMed Central

7 December 2017

Hector Morales

9

1 reference

Europe PubMed Central

7 December 2017

Christopher Konkoy

10

1 reference

Europe PubMed Central

7 December 2017

Matthias Herz

11

1 reference

Europe PubMed Central

7 December 2017

GLAD Study Group

12

1 reference

Europe PubMed Central

7 December 2017

publication date

1 May 2004

1 reference

Europe PubMed Central

7 December 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

7 December 2017

26

1 reference

Europe PubMed Central

7 December 2017

5

1 reference

Europe PubMed Central

7 December 2017

680-693

1 reference

Europe PubMed Central

7 December 2017

Insulin resistance: the fundamental trigger of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990068-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990068-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990068-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Established therapies for diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990068-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A dose-response study of glimepiride in patients with NIDDM who have previously received sulfonylurea agents. The Glimepiride Protocol #201 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990068-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term treatment of type 2 diabetic patients with the new oral antidiabetic agent glimepiride (Amaryl): a double-blind comparison with glibenclamide

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990068-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990068-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular effects of conventional sulfonylureas and glimepiride

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990068-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Peroxisome proliferator-activated receptor agonists, hyperlipidaemia, and atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990068-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990068-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990068-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Correct homeostasis model assessment (HOMA) evaluation uses the computer program

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990068-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin sensitivity and its measurement: structural commonalities among the methods

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990068-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990068-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Glimepiride improves both first and second phases of insulin secretion in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990068-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990068-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical evaluation of glimepiride versus glyburide in NIDDM in a double-blind comparative study. Glimepiride/Glyburide Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990068-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990068-9

7 January 2021

based on heuristic

inferred from DOI database lookup

LDL-cholesterol/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990068-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolic and additional vascular effects of thiazolidinediones.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990068-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-response effect of pioglitazone on insulin sensitivity and insulin secretion in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990068-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of troglitazone on body fat distribution in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990068-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Thiazolidinedione derivative improves fat distribution and multiple risk factors in subjects with visceral fat accumulation--double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990068-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990068-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Sulphonylurea-induced hypoglycaemia in type 2 diabetes mellitus: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990068-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990068-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of pioglitazone compared with metformin on glycemic control and indicators of insulin sensitivity in recently diagnosed patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990068-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990068-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(04)90068-9

1 reference

Europe PubMed Central

7 December 2017

1 reference

Europe PubMed Central

7 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44953741&oldid=2059447563"